Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mark Shlapobersky"'
Autor:
Eli Magen, Sumit Mukherjee, Mahua Bhattacharya, Rajesh Detroja, Eugene Merzon, Idan Blum, Alejandro Livoff, Mark Shlapobersky, Gideon Baum, Ran Talisman, Evgenia Cherniavsky, Amir Dori, Milana Frenkel-Morgenstern
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1135 (2022)
Initial clinical trials and surveillance data have shown that the most commonly administered BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA vaccine-induced mild to moderate adverse events were recently reported.
Externí odkaz:
https://doaj.org/article/02f0b1ca116a48f4bc9721c9f8a430de
Autor:
Bar Kaufman, Orli Abramov, Anna Ievko, Daria Apple, Mark Shlapobersky, Irit Allon, Yariv Greenshpan, Baisali Bhattachrya, Ofir Cohen, Tatiana Charkovsky, Alexandra Gayster, Ruthy Shaco-Levy, Keren Rouvinov, Alejandro Livoff, Moshe Elkabets, Angel Porgador
Publikováno v:
Science Advances. 9
Accurate predictive biomarkers of response to immune checkpoint inhibitors (ICIs) are required for better stratifying patients with cancer to ICI treatments. Here, we present a new concept for a bioassay to predict the response to anti-PD1 therapies,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54a55f7b84b5af94a02a60c6ea63b3aa
https://doi.org/10.1126/sciadv.adg2809
https://doi.org/10.1126/sciadv.adg2809
Autor:
Bar Kaufman, Orli Abramov, Anna Yevko, Daria Apple, Mark Shlapobersky, Yariv Greenshpan, Ruthy Shaco-Levy, Keren Roubinov, Alejandro Liboff, Moshe Elkabets, Angel Porgador
Accurate predictive biomarkers of response to immune checkpoint inhibitors (ICIs) are required for better stratifying cancer patients to ICI treatments. Here, we present a new concept for a bioassay to predict the response to anti-PD1 therapies, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ff1211146631540556dc67d154f48cb
https://doi.org/10.1101/2023.02.09.527671
https://doi.org/10.1101/2023.02.09.527671
Autor:
Yaseen Awad-Igbaria, Shilo Dadon, Alon Shamir, Alejandro Livoff, Mark Shlapobersky, Jacob Bornstein, Eilam Palzur
Publikováno v:
Journal of inflammation research. 15
Yaseen Awad-Igbaria,1,2 Shilo Dadon,1,2 Alon Shamir,3,4 Alejandro Livoff,5 Mark Shlapobersky,5 Jacob Bornstein,1,2,* Eilam Palzur2,* 1Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel; 2The Research Institute of Galilee M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52413412b05688e7019b0ac0c3ff3d11
https://pubmed.ncbi.nlm.nih.gov/35845089
https://pubmed.ncbi.nlm.nih.gov/35845089
Autor:
Eilon Barnea, Nataly Mancette Rijensky, Aron Popovtzer, Mark Shlapobersky, Nir Peled, Eli Rosenbaum, Dafna Perry, Neta Moskovits, Alejandro Livoff, Arie Admon, Netta R. Shraga, Itzhak Haviv, Eitan Rubin, Solomon M. Stemmer
Publikováno v:
Molecular & Cellular Proteomics : MCP
Sufficient tumor tissues are often not available for large HLA peptidome analysis. We demonstrate here that using patient derived xenograft (PDX) tumors are a useful source of large tumors for obtaining detailed and authentic HLA peptidomes that enab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::093ab8e5291ef23b497b0b45618b68b3
https://doi.org/10.1074/mcp.ra119.001876
https://doi.org/10.1074/mcp.ra119.001876
Autor:
Noam, Asna, Mark, Shlapobersky, Moshe, Schaffer, Tatiana, Harkovsky, Hananya, Vaknine, Yaron, Mintz, Gil, Ohana, Alejandro, Livoff
Publikováno v:
Harefuah. 161(1)
Plasmacytoma is a malignant tumor of the plasma cells. Extra-medullary plasmacytoma is rare and with an even lower incidence appears as a primary tumor of the stomach. Initial onset of the disease in the upper gastrointestinal tract is reported in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::73c524f76142d13f4a3b7d80ef3fa2d7
https://pubmed.ncbi.nlm.nih.gov/35077056
https://pubmed.ncbi.nlm.nih.gov/35077056
Autor:
Qun Wei, Mark Shlapobersky, Sean M. Sullivan, Ronald L. Veselenak, Nigel Bourne, Richard B. Pyles
Publikováno v:
Vaccine. 30:7046-7051
Here we describe studies in the guinea pig model of genital herpes to evaluate a novel plasmid DNA (pDNA) vaccine encoding the HSV-2 glycoprotein D and UL46 and UL47 genes encoding tegument proteins VP11/12 and VP 13/14 (gD2/UL46/UL47), formulated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee25758d1be447c02957f19073a95cb5
https://doi.org/10.1016/j.vaccine.2012.09.057
https://doi.org/10.1016/j.vaccine.2012.09.057
Autor:
Ronit Sarid, Jeremy Don, Mark Katzenellenbogen, Ramy R. Avtalion, Mark Shlapobersky, Michael S. Sinyakov
Publikováno v:
Virology. 399(2):239-247
We report here an outbreak of an acute disease that caused high mortality rate in laboratory-reared tilapia larvae. The disease was initially observed in inbred gynogenetic line of blue tilapia larvae (Oreochromis aureus) and could be transmitted to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bab537de07af1591e0a386ee2498a3
Autor:
Mark Shlapobersky, Alain Rolland, Rodrick Planchon, Qun Wei, Adrian Vilalta, Sean M. Sullivan
Publikováno v:
Vaccine. 27:7409-7417
Cationic lipids have been used as delivery systems to enhance the performance of vaccines and immunotherapeutics. However, little is known about the effect of administration of cationic lipid-formulated vaccines on gene expression. This study used DN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a94690bab3177d9e578165efaecb9e66
https://doi.org/10.1016/j.vaccine.2009.08.075
https://doi.org/10.1016/j.vaccine.2009.08.075
Autor:
Denis Rusalov, Jukka Hartikka, Qun Wei, Mark Shlapobersky, Larry R. Smith, Catherine K. Yang, Ming Ye, Alain Rolland, Vesselina Bozoukova, Adrian Vilalta
Publikováno v:
Vaccine. 27:6399-6403
Mice were immunized either with unadjuvanted seasonal trivalent influenza vaccine (TIV) or TIV formulated with Vaxfectin, a cationic lipid-based adjuvant. Increasing doses of Vaxfectin resulted in increased hemagglutination-inhibition or anti-TIV ELI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acdfe7ab2094b957a4cfcd45abd93918
https://doi.org/10.1016/j.vaccine.2009.06.014
https://doi.org/10.1016/j.vaccine.2009.06.014